-
Speaker
List
Print
-
All Conference Hall No.1(2F) Conference Hall No.5-A(1F) Conference Hall No.5-B(1F) Conference Hall No.5-C(1F) Conference Hall No.5-D(1F) Conference Hall No.2-A(2F) Conference Hall No.2-B(2F) Conference Hall No.2-C(2F) Conference Hall No.2-AB(2F) Conference Hall No.3(Vascular care)(1F) Convention Hall No.2(2F) Conference Hall 201-A(2F) Conference Room 201-AB(2F) Conference Room 201-ABC(2F) Conference Room 201-BC(2F) Conference Room 201-D(2F) Conference Room 201-CD(2F) Coference Room No.307(3F) Conference Room No.308(3F) Conference Hall No.2-VIP-room-A(2F) Electronic Poster Machine:Conference Hall No.4(1F) Satellite Symposium
16:38-17:30
IUA-Youngth committee -Special Session
Moderator: Wei Liang China , Donghua Ji China , Yangchenxi Ou China , Zhanfeng Sun China |
|||||
---|---|---|---|---|---|
NO./编号 | Time/时间 | Type/类型 | Subject/题目 | Speaker/讲者 | |
1 | 16:38-16:44 | Symposium |
An overview of vascular care in Bangladesh: our achievements and future plan |
Shantonu Kumar Ghosh Bangladesh |
|
2 | 16:44-16:50 | Symposium |
Evolution of vascular surgery and future perspectives for a surgeon in Turkey |
Evren Özçınar Turkey |
|
3 | 16:50-16:56 | Symposium |
Difficulties in establishing vascular practice in Developing country |
Omer Ehsan Pakistan |
|
4 | 16:56-17:02 | Symposium |
Effectiveness of percutaneous closure with proglide in accesses of the brachial and axillary artery |
Karol Lajam Dominican Republic |
|
5 | 17:02-17:08 | Symposium |
Management of Superior mesentric artery dissection |
Hyangkyoung Kim Korea |
|
6 | 17:08-17:14 | Symposium |
Carotid Body tumors: role of multidisciplinary approach and genetic background. single center e experience |
Mirko Menegolo Italy |
|
7 | 17:14-17:20 | Symposium |
The Outcome of Endovascular Fistula Salvage on failing-to-mature AV Fistules due to stenotic cause on Chronic Kidney Failure patient and the related factors. |
||
8 | 17:20-17:26 | Symposium |
Role of cilostazol in PAD after open & endovascular procedures . |
Hyangkyoung Kim Korea |
|
9 | 17:26-17:36 |
Discussion |